Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Potential Therapeutic Value of the STING Inhibitors
Shangran Zhang, Runan Zheng, Yanhong Pan, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3127-3127
Open Access | Times Cited: 23
Polysaccharides (pectin, mucilage, and fructan inulin) and their fermented products: A critical analysis of their biochemical, gut interactions, and biological functions as antidiabetic agents
Heba A. S. El‐Nashar, Mohamed Taleb, Mohamed El‐Shazly, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 662-693
Closed Access | Times Cited: 12
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Association between red cell distribution width—albumin ratio and all-cause mortality in intensive care unit patients with heart failure
Ni Li, Junling Li, Kai Wang
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Trang T. D. Luong, Seonbu Yang, Jaetaek Kim
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Dysfunctional glucose metabolism triggers oxidative stress to induce kidney injury in diabetes
Meng Gao, Meng-Ting Dai, Guohua Gong
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access
Mapping the evolution of anti-diabetic polysaccharides research: Trends, collaborations, and emerging frontiers
Shengqi He, Taotao Xue, Ruoyu Geng, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177479-177479
Closed Access
L-arginine overdose is a potential risk factor for myocardial injury in patients with type 2 diabetes
Yan Chen, Meng-Ting Dai, Guohua Gong
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
Molecular cardiopharmacology and Therapeutics-I
Pooja Tiwary, Krishil Oswal, Dileep Kumar
Elsevier eBooks (2024), pp. 471-486
Closed Access
Overcoming CRISPR-Cas9 off-target prediction hurdles: A novel approach with ESB rebalancing strategy and CRISPR-MCA model
Yanpeng Yang, Yanyi Zheng, Quan Zou, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 9, pp. e1012340-e1012340
Open Access
The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats
E A Rodrigues, C. M. Rosa, Dijon Henrique Salomé de Campos, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Research Progress of Lipid Toxicity and Diabetic Heart Disease
慧娟 王
Advances in Clinical Medicine (2023) Vol. 13, Iss. 08, pp. 13074-13079
Closed Access
Page 1

Scroll to top